Table 2.
Per-Patient Direct Costs of Menopausal Symptoms and 15 Comparator Conditions
| Mean (SD), median (range) annual direct per-patient costs, US$a | |||||
|---|---|---|---|---|---|
| Condition | Inpatient visits | Outpatient visits | Emergency department visits | Office-based medical provider visits | Total |
| Menopausal symptoms (N = 401) | 0 (0) 0 (0–0) | 74 (720) 0 (0–8919) |
20 (320) 0 (0–6046) |
153 (581) 0 (0–6480) |
248 (1021) 0 (0–9575) |
| Diabetes ± complications (N = 1370) | 370 (5983) 0 (0–130,809) |
95 (1017) 0 (0–22,577) |
61 (965) 0 (0–31,382) |
1249 (17,130) 0 (0–441,684) |
1776 (18,671) 0 (0–446,231) |
| Disorders of lipid metabolism (N = 2525) | 4 (203) 0 (0–10,214) |
11 (249) 0 (0–11,289) |
0 (0) 0 (0–0) |
76 (665) 0 (0–28,236) |
91 (739) 0 (0–28,236) |
| Headache (N = 856) | 122 (2904) 0 (0–81,839) |
50 (467) 0 (0–5862) |
158 (1308) 0 (0–21,138) |
156 (772) 0 (0–11,905) |
486 (3737) 0 (0–97,932) |
| Cataract (N = 164) | 155 (1984) 0 (0–25,401) |
1287 (5237) 0 (0–40,308) |
0 (0) 0 (0–0) |
1998 (5671) 96 (0–46,632) |
3440 (7779) 186 (0–46,632) |
| Glaucoma (N = 148) | 0 (0) 0 (0–0) |
215 (1910) 0 (0–21,208) |
0 (0) 0 (0–0) |
671 (1367) 199 (0–10,105) |
885 (2400) 199 (0–22,542) |
| Essential hypertension (N = 3515) | 52 (1236) 0 (0–46,719) |
14 (306) 0 (0–13,616) |
77 (940) 0 (0–25,635) |
109 (609) 0 (0–20,586) |
252 (1976) 0 (0–63,516) |
| Influenza (N = 578) | 0 (0) 0 (0–0) |
5 (78) 0 (0–1425) |
26 (331) 0 (0–4973) |
55 (233) 0 (0–2659) |
86 (417) 0 (0–4973) |
| COPD/bronchiectasis (N = 697) | 2110 (32,116) 0 (0–642,742) |
53 (528) 0 (0–10,657) |
113 (630) 0 (0–6624) |
337 (3118) 0 (0–78,150) |
2614 (32,395) 0 (0–646,045) |
| Asthma (N = 869) | 213 (2765) 0 (0–42,549) |
57 (1227) 0 (0–35,487) |
202 (1999) 0 (0–36,541) |
137 (1182) 0 (0–32,012) |
607 (4038) 0 (0–51,095) |
| Esophageal disorders (N = 822) | 88 (2176) 0 (0–61,481) |
170 (1928) 0 (0–43,106) |
89 (917) 0 (0–16,580) |
169 (1252) 0 (0–24,762) |
516 (3328) 0 (0–61,481) |
| Urinary tract infections (N = 484) | 59 (950) 0 (0–18,177) |
14 (192) 0 (0–3960) |
207 (1156) 0 (0–13,122) |
310 (1796) 0 (0–32,326) |
591 (2357) 0 (0–32,326) |
| Osteoarthritis (N = 927) | 475 (6098) 0 (0–93,794) |
115 (1391) 0 (0–28,880) |
31 (477) 0 (0–9767) |
382 (1956) 0 (0–40,187) |
1002 (6863) 0 (0–104,853) |
| Osteoporosis (N = 1105) | 0 (0) 0 (0–0) |
5 (96) 0 (0–2382) |
0 (0) 0 (0–0) |
20 (173) 0 (0–2832) |
26 (219) 0 (0–4474) |
| Anxiety disorder (N = 1231) | 288 (3768) 0 (0–77,249) |
5 (141) 0 (0–4788) |
63 (681) 0 (0–12,849) |
264 (2294) 0 (0–68,898) |
620 (4506) 0 (0–77,249) |
| Mood disorder (N = 1491) | 173 (3090) 0 (0–105,118) |
72 (1339) 0 (0–42,330) |
18 (366) 0 (0–12,197) |
452 (2037) 0 (0–36,753) |
714 (4399) 0 (0–125,423) |
NOTE: The costs were of women aged 45 to 65 years who had not had a hysterectomy and who participated in the 2010, 2011, and/or 2012 MEPS-HC (descriptive statistics, pooled).
a
Costs are rounded to the nearest dollar.
COPD indicates chronic obstructive pulmonary disease; MEPS-HC, Medical Expenditure Panel Survey Household Component; SD, standard deviation.